
@ShahidNShah
Despite the ongoing shift to value-based care, health systems still rely heavily on procedures, imaging, and infusions to drive substantial portions of their top-line revenue, and Covid-19 has opened the industry’s eyes to the fragility of these revenue streams. Hopefully, this realization leads to further engagement in value-based initiatives – at minimum, as a way to hedge against future disruptions of fee-for-service revenue, but ultimately because these reimbursement models have the opportunity to deliver higher quality care at lower costs.
Even aside from pandemics, there are always threats to an organization’s fee-for-service revenue that present risks, such as competition in the market, losing a physician specialty group, and more.
Continue reading at medcitynews.com
While the COVID-19 pandemic has placed unparalleled demands on modern healthcare systems, the industry’s response has vividly demonstrated its resilience and ability to bring innovations to market …
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm